![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Protein Design Increases ESP Price
Protein Design Increases ESP Price
Biotechnology firm Protein Design Labs has said it increased the price it will pay for ESP Pharma after the Edison, N.J.-based drugmaker acquired rights to a heart attack treatment. In late January, Protein Design Labs said it agreed to buy ESP for $300 million in cash and $175 million in stock. The company said it increased its purchase price by $25 million cash because of ESP's newly acquired rights of heart attack treatment Retavase, made by Johnson & Johnson unit Centocor.
Yahoo News (http://biz.yahoo.com/ap/050201/protein_design_esp_1.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct